#inspiremd

This text was written by Observe Looking for Alpha’s transcripts workforce is liable for the event of all of our transcript-related tasks. We presently publish hundreds of quarterly earnings calls per quarter on our website and are persevering with to develop and develop our protection. The aim of this profile is to permit us to share with our readers new transcript-related developments.…

InspireMD Inc. (NYSE: NSPR) reported revenue of $1.01 million for the fourth quarter of 2019, up 23% compared to the same period last year.

Net loss was $2.5 million, or $0.57 per share, compared to $2.2 million, or $2.64 per share, last year.

The company generated CGuard EPS revenue of $921,000, up 31% over the prior-year period.

No surprises expected when InspireMD (NSPR) reports Q4 earnings

InspireMD (NYSE: NSPR) has incurred losses consistently over the past several years. Of late, shareholders have been apprehensive about their investments as things went from bad to worse, to the point where the company even faced de-listing from the New York Stock Exchange.

Related: InspireMD Q2 Earnings Conference Call Transcript

The Israel-based medical device maker will be publishing its…

InspireMD posts 59% plunge in Q1 revenues on third-party equipment failure

Israel-based medical device company InspireMD (NYSE: NSPR) reported first-quarter loss of $3.82 per share, much wider than the loss of $2.50 per share projected by analysts.

Contrary to analysts’ expectations, revenues for the quarter plunged 59% to $$415,000, primarily driven by a 55% decrease in sales of CGuard EPS and a 78% fall in sales of MGuard EPS. Both decreases were due to…

InspireMD, ReWalk Robotics decline on stock offering

Two Israeli firms – InspireMD (NYSE: NSPR) and ReWalk Robotics (NASDAQ: RWLK) – saw their shares fall during the pre-market hours of Thursday on announcements of their respective stock offerings.

Shares of Tel Aviv-based InspireMD plunged 30% during morning trade after the company priced its public offeringof 486,957 common stock at $5 apiece. The company, which makes Carotid Embolic Prevention…

InspireMD (NSPR:ASE) and McClatchy (MNI:ASE) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash valuemeaning…

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash valuemeaning…

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com

I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash valuemeaning…